Alteraciones citogenéticas en meningiomas y su impacto en la evolución de la enfermedad

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Medicina Clinica

• Publication date

  2007-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0025-7753(07)72543-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The Cytogenetic Relationship between Primary and Recurrent Meningiomas Points to the Need for New Treatment Strategies in Cases at High Risk of Relapse

  2006cited by this paper
• Interstitial loss and gain of sequences on chromosome 22 in meningiomas with normal karyotype.

  2005cited by this paper
• GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis.

  2005cited by this paper
• Epidemiology of intracranial meningioma.

  2005cited by this paper
• Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.

  2005cited by this paper
• Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature

  2004cited by this paper
• Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.

  2004cited by this paper
• Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?

  2004cited by this paper
• New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology.

  2003cited by this paper
• Combined Modality Therapy of Central Nervous System Tumors

  2003cited by this paper
• Spinal meningiomas: surgical management and outcome.

  2003cited by this paper
• TP53 mutations in human meningiomas.

  2002cited by this paper
• Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.

  2002cited by this paper
• Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas.

  2002cited by this paper
• Allelic Gain and Amplification on the Long Arm of Chromosome 17 in Anaplastic Meningiomas

  2002cited by this paper
• IMMUNOHISTOCHEMICAL DETECTION OF PROGESTERONE RECEPTORS AND THE CORRELATION WITH KI-67 LABELING INDICES IN PARAFFIN-EMBEDDED SECTIONS OF MENINGIOMAS

  2002cited by this paper
• The WHO Classification of Tumors of the Nervous System

  2002cited by this paper
• A Role for Chromosome 9p21 Deletions in the Malignant Progression of Meningiomas and the Prognosis of Anaplastic Meningiomas

  2002cited by this paper
• Monosomía 1p y fosfatasa alcalina en meningiomas. Estudio clinicopatológico, histoquímico y genético en 10 tumores

  2002cited by this paper
• Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome-specific probes.

  2002cited by this paper
• Loss of 1p in recurrent meningiomas. a comparative study in successive recurrences by cytogenetics and fluorescence in situ hybridization.

  2001cited by this paper
• Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.

  2001cited by this paper
• Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases

  2001cited by this paper
• Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.

  2001cited by this paper
• Chromosome 1p and 14q FISH Analysis in Clinicopathologic Subsets of Meningioma: Diagnostic and Prognostic Implications

  2001cited by this paper
• Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM‐1 and DCC tumor suppressor genes on the long arm of chromosome 18

  2001cited by this paper
• Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases.

  2001cited by this paper
• PS6K amplification characterizes a small subset of anaplastic meningiomas.

  2001cited by this paper
• Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation‐induced human meningiomas

  2001cited by this paper
• Analysis of p73 gene in meningiomas with deletion at 1p.

  2001cited by this paper
• Gains of chromosome 22 by fluorescence in situ hybridization in the context of an hyperdiploid karyotype are associated with aggressive clinical features in meningioma patients

  2001cited by this paper
• [A study of reduction of NF 2 protein, mRNA and loss of 22 q in sporadic meningiomas].

  2000cited by this paper
• Frequent Loss of 1p32 Region but no Mutation if the p18 Tumor Suppressor Gene in Meningiomas

  2000cited by this paper
• Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.

  2000cited by this paper
• A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients

  2000cited by this paper
• Merlin, DAL‐1, and Progesterone Receptor Expression in Clinicopathologic Subsets of Meningioma: A Correlative Immunohistochemical Study of 175 Cases

  2000cited by this paper
• High-resolution analysis of chromosome arm 1p alterations in meningioma.

  2000cited by this paper
• Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.

  1999cited by this paper
• Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.

  1999cited by this paper
• Risk Factors Predicting Recurrence in Patients Operated on for Intracranial Meningioma. A Multivariate Analysis

  1999cited by this paper
• NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas

  1999cited by this paper
• Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.

  1999cited by this paper
• Predicting meningioma recurrence

  1999cited by this paper
• Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.

  1998cited by this paper
• Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in Situ hybridization

  1998cited by this paper
• Contribution of cytogenetics and FISH in the diagnosis of meningiomas. A study of 189 tumors.

  1998cited by this paper
• Detection of gains and losses in 18 meningiomas by comparative genomic hybridization.

  1998cited by this paper
• Spinal meningiomas: a 20-year review.

  1998cited by this paper
• Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas

  1998cited by this paper
• DNA ploidy and cell‐cycle analysis in intracranial meningiomas and hemangiopericytomas: A study with high‐resolution DNA flow cytometry

  1998cited by this paper
• Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.

  1998cited by this paper
• Analysis of the PTEN gene in human meningiomas

  1998cited by this paper
• Chromosomal losses and gains in meningiomas: comparative genomic hybridization (CGH) study of the whole genome.

  1998cited by this paper
• Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988.

  1998cited by this paper
• Study of the DNA content by flow cytometry and proliferation in 281 brain tumors.

  1997cited by this paper
• Loss of Alkaline Phosphatase Activity in Meningiomas: A Rapid Histochemical Technique Indicating Progression‐associated Deletion of a Putative Tumor Suppressor Gene on the Distal Part of the Short Arm of Chromosome 1

  1997cited by this paper
• 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization

  1997cited by this paper
• Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative `tumor progression' locus

  1997cited by this paper
• Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study

  1997cited by this paper
• Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.

  1997cited by this paper
• Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.

  1997cited by this paper
• Epidemiology and etiology of intracranial meningiomas: A review

  1996cited by this paper
• Microsatellite instability analysis of primary human brain tumors.

  1996cited by this paper
• Intratumorous heterogeneity of chromosome 10 and 17 in meningiomas using non-radioactive in situ hybridization.

  1996cited by this paper
• Neurofibromatosis 2: loss of merlin's protective spell.

  1996cited by this paper
• Recurrence of cranial base meningiomas.

  1996cited by this paper
• Role of genomic instability in meningioma progression

  1996cited by this paper
• Cytogenical analysis of brain tumors by FISH (fluorescence in situ hybridization) and FCM (flow cytometry).

  1995cited by this paper
• Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas

  1995cited by this paper
• Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.

  1995cited by this paper
• Cytogenetic, Molecular Genetic and Pathological Analyses in 126 Meningiomas

  1995cited by this paper
• Detection of TP53 gene mutation in human meningiomas: A study using immunohistochemistry, polymerase chain reaction/single‐strand conformation polymorphism and dna sequencing techniques on paraffin‐embedded samples

  1995cited by this paper
• Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.

  1995cited by this paper
• Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.

  1995cited by this paper
• Genetic Aberrations in Human Brain Tumors

  1994cited by this paper
• Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.

  1994cited by this paper
• Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression

  1994cited by this paper
• Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas

  1994cited by this paper
• Allelic loss at 1 p is associated with tumor progression of meningiomas

  1994cited by this paper
• Chromosome abnormalities in meningeal neoplasms: do they correlate with histology?

  1994cited by this paper
• Chromosome studies in 70 brain tumors with special attention to sex chromosome loss and single autosomal trisomy.

  1994cited by this paper
• Deletions on chromosome 22 in sporadic meningioma

  1994cited by this paper
• 1; 19 Translocation in human meningioma

  1993cited by this paper
• Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches.

  1993cited by this paper
• Clinico-pathological correlations in meningiomas: a DNA and immunohistochemical study.

  1993cited by this paper
• Cosmid mapping and locus linkage within the human chromosomal region 22q13.1.

  1993cited by this paper
• Atypical and malignant meningiomas: a clinicopathological review.

  1993cited by this paper
• Epidemiology of intracranial meningioma

  1993cited by this paper
• Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.

  1993cited by this paper
• Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.

  1992cited by this paper
• Correlation between cytogenetic and histopathological findings in 75 human meningiomas.

  1992cited by this paper
• A t(4;22) in a meningioma points to the localization of a putative tumor-suppressor gene.

  1991cited by this paper
• Molecular genetic analysis of chromosome 22 in 81 cases of meningioma.

  1990cited by this paper
• The Molecular Genetics of Meningiomas

  1990cited by this paper
• Meningiomas: karyotypes and histological patterns.

  1989cited by this paper
• Cytogenetic studies of 19 meningiomas and their clinical significance. I.

  1989cited by this paper
• Incidence and clinicopathological features of meningioma.

  1989cited by this paper
• Molecular genetic approach to human meningioma: loss of genes on chromosome 22.

  1987cited by this paper
• Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma.

  1987cited by this paper
• Mechanisms of tumor progression.

  1986cited by this paper

• Molecular diagnosis and treatment of meningiomas: an expert consensus (2022)

  2022cites this paper
• Growth arrest–specific 2 protein family: Structure and function

  2020cites this paper
• DNA Hypermethylation and Histone Modifications Downregulate the Candidate Tumor Suppressor Gene RRP22 on 22q12 in Human Gliomas

  2012cites this paper
• Genomic and Expression Alterations of Tumor Suppressor Genes in Meningioma Development, Progression and Recurrence

  2012cites this paper
• Molecular analysis of small Ras-related GTPase genes with potential tumor suppressor function in human gliomas

  2011cites this paper